XML 60 R49.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Collaborative Agreements (Details) - USD ($)
 1 Months Ended 3 Months Ended 6 Months Ended
Apr. 30, 2020
Jan. 31, 2020
Aug. 31, 2019
Oct. 31, 2018
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Dec. 31, 2023
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                  
Revenue from related parties         $ 100,762 $ 225,971 $ 100,762 $ 340,914  
Advaccine | Collaborative Arrangement, Product                  
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                  
Upfront payment received         0 1,200,000 0 2,400,000  
ApolloBio | Collaborative Arrangement, Product                  
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                  
Additional revenue to be achieved             $ 20,000,000.0    
Royalty period (in years)             10 years    
Revenue from related parties         101,000 0 $ 101,000 0  
Coalition for Epidemic Preparedness Innovations | Collaborative Arrangement, Product                  
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                  
Collaborative agreement, funding to be received $ 6,900,000                
Coalition for Epidemic Preparedness Innovations | Collaborative Arrangement, Product | Lassa Fever and MERS Vaccine                  
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                  
Collaborative agreement, funding to be received             $ 56,000,000    
Collaborative agreement, period to receive funding for research and development (in years)             5 years    
Collaborative agreement, funding received         0 303,000 $ 0 1,900,000  
Accrued liabilities         2,200,000   2,200,000   $ 2,200,000
Coalition for Epidemic Preparedness Innovations | Collaborative Arrangement, Product | INO-4800                  
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                  
Collaborative agreement, funding to be received 1,300,000 $ 9,000,000.0              
Collaborative agreement, funding received         0 135,000 0 188,000  
Coalition for Epidemic Preparedness Innovations | Collaborative Arrangement, Product | CELLECTRA 3PSP Proprietary Smart Device                  
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                  
Collaborative agreement, funding to be received $ 5,000,000.0                
Bill and Melinda Gates Foundation | Collaborative Arrangement, Product | DNA-Encoded Monoclonal Antibody Technology                  
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                  
Collaborative agreement, funding received     $ 1,100,000 $ 2,200,000 0 $ 12,000 39,000 $ 70,000  
Accrued liabilities         $ 49,000   $ 49,000